Hospira Inc. (HSP)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
F. Michael Ball
Employees:
19,000
275 FIELD DR, LAKE FOREST, IL 60045
8479376472

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Hospira, Inc. provides injectable drugs and infusion technologies to develop, manufacture, distribute, and market products worldwide. The company operates through Americas, EMEA, and APAC segments.

Data derived from most recent annual or quarterly report
Market Cap 15.555 Billion Shares Outstanding172.934 Million Avg 30-day Volume 2.948 Million
P/E Ratio37.6339 Dividend Yield0.0 EPS1.28
Price to Revenue3.37 Debt to Equity0.4845 EBITDA867.6 Million
Price to Book Value0.0 Operating Margin13.3575 Enterprise Value16.298 Billion
Current Ratio2.523 EPS Growth1.311 Quick Ratio1.272
1 Yr BETA 0.6639 52-week High/Low 0.0 / Profit Margin8.9546
Operating Cash Flow Growth51.9557 Free Cash Flow to Firm (FCFF) TTM 3.958 Billion Free Cash Flow to Equity (FCFE) TTM45.817 Million
Altman Z-Score2.6888

Are you looking for this stock instead?

View SEC Filings from HSP instead.

View recent insider trading info

Hospira Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding HSP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HSP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WHEELER MARK F

  • Director
 No longer subject to file 2015-09-03 0

BALL F MICHAEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 No longer subject to file 2015-09-03 0

BOWLES BARBARA L

  • Director
 No longer subject to file 2015-09-03 0

BAILEY IRVING W II

  • Director
 No longer subject to file 2015-09-03 0

HALE ROGER W

  • Director
 No longer subject to file 2015-09-03 0

FENTON DENNIS M

  • Director
 No longer subject to file 2015-09-03 0

STALEY JOHN C

  • Director
 No longer subject to file 2015-09-03 0

DEMPSEY WILLIAM G

  • Director
 No longer subject to file 2015-09-03 0

SOKOLOV JACQUE J

  • Director
 No longer subject to file 2015-09-03 0

SMITH BRIAN J SVP AND SPECIAL COUNSEL

  • Officer
 No longer subject to file 2015-09-03 0

WERNER THOMAS E SVP, FINANCE & CFO

  • Officer
 No longer subject to file 2015-09-03 0

HOFFMAN RICHARD J CVP, CONTROLLER & CAO

  • Officer
 No longer subject to file 2015-09-03 0

MEYERS KENNETH F SVP, CHIEF HUMAN RESOURCES OFR

  • Officer
 No longer subject to file 2015-09-03 0

VON PRONDZYNSKI HEINO

  • Director
 No longer subject to file 2015-09-03 0

ENDICOTT DAVID J. PRES., HOSPIRA MEDICAL DEVICES

  • Officer
 No longer subject to file 2015-09-03 0

DAVIES RICHARD JOHN SVP, CHIEF COMMERCIAL OFFICER

  • Officer
 No longer subject to file 2015-09-03 0

KAUFMAN ZENA G. SVP, QUALITY

  • Officer
 No longer subject to file 2015-09-03 0

STOBER MATTHEW R SVP, OPERATIONS

  • Officer
 No longer subject to file 2015-09-03 0

YOSKOWITZ MARC J SVP, STRATEGY & CORPORATE DEV

  • Officer
 No longer subject to file 2015-09-03 0

GENDRON MARY SVP, CHIEF INFORMATION OFFICER

  • Officer
 No longer subject to file 2015-09-03 0

BEDWARD ROYCE SVP, GENERAL COUNSEL AND SEC'Y

  • Officer
 No longer subject to file 2015-09-01 0

RAMACHANDRA SUMANT SVP & CHIEF SCIENTIFC OFCR

  • Officer
 No longer subject to file 2015-08-14 0

CURRAN CONNIE R

  • Director
 46,390 2014-05-16 0

JONES DAPHNE E SVP, CHIEF INFORMATION OFFICER

  • Officer
 13,393 2014-02-26 0

ELLIOT JOHN B SVP, OPERATIONS

  • Officer
 5,301 2013-12-31 0

RYDING NEIL SVP, DEVICES

  • Officer
 31,962 2013-09-27 0

HARDY JAMES H JR SVP, OPERATIONS

  • Officer
 0 2012-03-01 0

BEGLEY CHRISTOPHER B CHAIRMAN AND CEO

  • Officer
  • Director
 273,167 2011-02-24 0

SQUARER RON CHIEF COMMERCIAL OFFICER

  • Officer
 23,472 2011-02-24 0

DUBOIS FRANCOIS L SENIOR VICE PRESIDENT, QUALITY

  • Officer
 0 2011-02-24 0

KEARNEY TERRENCE C CHIEF OPERATING OFFICER

  • Officer
 51,228 2010-12-15 0

MATRICARIA RONALD A

  • Director
 13,767 2009-06-30 0

OGUNRO EDWARD A SVP

  • Officer
 63,859 2007-09-10 0

YIEN VALENTINE CORP. VP CONTROLLER

  • Officer
 21,113 2007-05-15 0

ARNOTT JOHN SVP, GLOBAL COMM. OPS.

  • Officer
 39,150 2006-11-24 0

JONES DAVID A SR/KY

  • Director
 206,468 2006-06-30 0

WEISS WILLIAM L

  • Director
 6,422 2006-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments